S J Forman Selected Research

S J Forman Research Topics

Disease

11	Neoplasms (Cancer) 01/2017 - 02/2000
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2011 - 02/2000
9	Leukemia 01/2015 - 01/2000
7	Lymphoma (Lymphomas) 01/2006 - 01/2000
7	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2004 - 01/2000
4	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 03/2000
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2015 - 05/2000
4	Hematologic Neoplasms (Hematological Malignancy) 04/2013 - 02/2000
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2012 - 03/2000
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2008 - 02/2000
3	Infections 12/2008 - 05/2001
2	Breast Neoplasms (Breast Cancer) 12/2009 - 06/2001
2	Multiple Myeloma 05/2006 - 02/2000
2	HIV Infections (HIV Infection) 10/2003 - 08/2000
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Bites and Stings (Sting) 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 03/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2012
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2011
1	Iron Overload 12/2008
1	Vaccinia 08/2008
1	Refractory Anemia with Excess of Blasts (RAEM) 11/2007
1	Disease Progression 10/2003
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2003
1	Stomatitis 06/2001
1	Carcinoma (Carcinomatosis) 06/2001
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2001
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2000
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 08/2000
1	Second Primary Neoplasms (Neoplasms, Second) 06/2000

Drug/Important Bio-Agent (IBA)

5	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2004 - 01/2000
3	Methotrexate (Mexate)FDA LinkGeneric 01/2001 - 01/2000
2	Chimeric Antigen ReceptorsIBA 01/2017 - 08/2013
2	Imatinib Mesylate (Gleevec)FDA Link 04/2008 - 06/2005
2	Melphalan (Alkeran)FDA LinkGeneric 11/2007 - 06/2004
2	fludarabineIBA 11/2007 - 06/2004
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2004 - 10/2003
2	Interleukin-2 (IL2)IBA 01/2003 - 02/2000
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2001 - 01/2001
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2001 - 01/2001
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2000 - 11/2000
2	Prednisone (Sone)FDA LinkGeneric 01/2000 - 01/2000
1	Brentuximab VedotinIBA 01/2018
1	Bispecific AntibodiesIBA 01/2017
1	Surface Antigens (Surface Antigen)IBA 01/2017
1	blinatumomabIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2015
1	Peptides (Polypeptides)IBA 08/2013
1	Pharmaceutical PreparationsIBA 03/2012
1	Farnesyltranstransferase (Farnesyltransferase)IBA 10/2011
1	tipifarnib (R115777)IBA 10/2011
1	Ferritins (Ferritin)IBA 12/2008
1	Immunodominant EpitopesIBA 08/2008
1	VaccinesIBA 08/2008
1	Tyrosine Kinase InhibitorsIBA 04/2008
1	Thalidomide (Thalomid)FDA Link 05/2006
1	Phosphotransferases (Kinase)IBA 06/2005
1	CytokinesIBA 01/2003
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2001
1	SteroidsIBA 05/2001
1	Filgrastim (Neupogen)FDA Link 01/2001
1	Dihydrotachysterol (AT 10)IBA 01/2001
1	nuclear pore complex protein 98IBA 11/2000
1	lens epithelium-derived growth factorIBA 11/2000
1	Etoposide (VP 16)FDA LinkGeneric 09/2000
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2000
1	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2000
1	Biological ProductsIBA 07/2000
1	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2000
1	InterleukinsIBA 02/2000

Therapy/Procedure

16	Therapeutics 01/2018 - 01/2000
10	Stem Cell Transplantation 01/2018 - 03/2000
9	Transplantation 11/2007 - 02/2000
7	Cell Transplantation 01/2018 - 02/2000
6	Drug Therapy (Chemotherapy) 01/2015 - 01/2000
5	Hematopoietic Stem Cell Transplantation 12/2009 - 05/2000
3	Immunotherapy 01/2017 - 02/2000
3	Autologous Transplantation 10/2003 - 02/2000
1	Adjuvant Chemotherapy 12/2009
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2001
1	Highly Active Antiretroviral Therapy (HAART) 08/2000
1	Radiotherapy 06/2000
1	Chemoradiotherapy 03/2000
1	Homologous Transplantation 02/2000